Literature DB >> 24965531

Analgesic effects of β-phenylethylamine and various methylated derivatives in mice.

Aron D Mosnaim1, Thomas Hudzik, Marion E Wolf.   

Abstract

Administration of β-phenylethylamine (PEA), the simplest endogenous neuroamine, and various methylated PEA derivatives including α-methyl PEA (amphetamine, AMP) elicits analgesia in mice. Five or 20 min after intraperitoneal PEA injection of as little as 6 mg/kg resulted in an increased latency response time (from 2.4 ± 0.4 to 8.5 ± 2.3 or 7.0 ± 3.0 s, respectively) to the thermal stimulus (hot-plate test), which reached statistical significance at the 15 mg/kg (20 min; 13.1 ± 0.4 s) or 25 mg/kg dose (5 min; 15.3 ± 4.1 s). This PEA effect, was dose-dependent (albeit non-linear: 6, 12, 15, 25, 50 and 100 mg/kg), reached the cut-off time of 45 s at the upper PEA dose (5 min), and it was consistently enhanced by pretreatment with the monoamine oxidase inhibitor pargyline (P). Methylated PEA derivatives (15 and 100 mg/kg dose) produced various degrees of analgesia (in decreasing order p-Me PEA > PEA > N,N-diMe PEA > N-Me PEA) which, likewise to PEA itself, were consistently increased by P and declined over time (mice tested 5, 20 and 60 min after amine injection); small but statistically significant o- and β-Me PEA antinociceptive effects (5 min) were observed only at the higher dose (in the presence of P for β-Me PEA). A small analgesic effect was observed after the administration of AMP (5 or 10 mg/kg) which failed, even after P, to reach statistically significance. Independent of the amine and concentration tested, individual compound's antinociceptive properties were reliably increased by P (exception of AMP), decreased by reserpine (R) or haloperidol (H), and remained essentially unchanged after naloxone (N) administration suggesting the involvement of catecholamines, but not opioid peptides, in their observed analgesic effects. Injection of P + N produced results similar to those seen after P alone. Under the experimental conditions described neither P, R, H or N had any effects by themselves. These findings suggest additional understanding of the mechanism of action responsible for the analgesic effects of these amines would be of interest, leading further to controlled studies on their alleged usefulness as weight reducing agents and sport performance enhancers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24965531     DOI: 10.1007/s11064-014-1354-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

Review 1.  Receptors of mammalian trace amines.

Authors:  Anita H Lewin
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

2.  Enzymatic isotopic assay for and presence of beta-phenylethylamine in brain.

Authors:  J M Saavedra
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

3.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Authors:  J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

4.  Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine.

Authors:  Martina Fehler; Kenneth J Broadley; William R Ford; Emma J Kidd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-01       Impact factor: 3.000

5.  Rat brain-uptake index for phenylethylamine and various monomethylated derivatives.

Authors:  Aron D Mosnaim; Owen H Callaghan; Thomas Hudzik; Marion E Wolf
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

6.  Determination of regional distributions of phenylethylamine and meta- and para-tyramine in rat brain regions and presence in human and dog plasma by an ultra-sensitive negative chemical ion gas chromatography-mass spectrometric (NCI-GC-MS) method.

Authors:  D A Durden; B A Davis
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

Review 7.  The potential of trace amines and their receptors for treating neurological and psychiatric diseases.

Authors:  M D Berry
Journal:  Rev Recent Clin Trials       Date:  2007-01

Review 8.  Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators.

Authors:  Mark D Berry
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

9.  Direct effect of phenylethylamine upon isolated rat aortic strip.

Authors:  T R Hansen; J Greenberg; A D Mosnaim
Journal:  Eur J Pharmacol       Date:  1980-05-02       Impact factor: 4.432

Review 10.  Phenylethylamine in neuropsychiatric disorders.

Authors:  M E Wolf; A D Mosnaim
Journal:  Gen Pharmacol       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.